Metabolic Complications
Resources about metabolic complications for families and patients, from BC Children's Hospital Mental Health Services.
Resources for families
- Healthy Living for Families
- Patient and Family Guide to Second Generation Antipsychotics (PDF)
- SGAs, Insulin, Diet and Activity (PDF)
- SGAs, Prolactin, Diet and Activity (PDF)
- SGAs, Triglycerides, Diet and Activity (PDF)
- SGAs, Appetite, Diet and Activity (PDF)
- SGAs, Blood Pressure, Diet and Activity (PDF)
- SGAs, Cholesterol, Diet and Activity (PDF)
Metabolic assessment, screening and monitoring tools
- BC Revised Metabolic Assessment, Screening and Monitoring Tool (2014) (PDF)
- Measurement Guide for Metabolic Assessment, Screening & Monitoring Tool (PDF)
Second generation antipsychotics and metabolic complications
- Metabolic Monitoring Learning Program: This course provides an overview of first-generation antipsychotic (FGA) and second-generation antipsychotic (SGA) use in BC and Canada as it relates to children and youth. The three modules include a review of current approvals and prescription trends, examine the implications of SGA use and review evidence-informed practices for the monitoring and management of SGAs
- Evidence-Based Recommendations for Monitoring Safety of Second Generation Antipsychotics in Children and Youth (PDF)
- First Do No Harm: Promoting an evidence-based approach to atypical antipsychotic use in children and adolescents (PDF): Journal article reviewing the evidence for efficacy and metabolic effects of atypical antipsychotics (AAPs), and to propose a metabolic monitoring protocol for AAP use in children and adolescents
- Increased Prevalence of Obesity and Glucose Intolerance in Youth Treated With Second-Generation Antipsychotic Medications (PDF): Journal article comparing the rates of obesity, impaired fasting glucose (IFG), and type 2 diabetes between second-generation antipsychotic (SGA)-treated and SGA-naïve youth
- Management Recommendations for Metabolic Complications Associated with Second Generation Antipsychotic Use in Children and Youth (PDF): Previous guidelines have been developed for monitoring for metabolic and neurological complications. This is a complementary set of treatment recommendations if abnormal measurements or results are encountered
- Treatment Recommendations for Extrapyramidal Side Effects Associated with Second Generation Anti-psychotic Use in Children and Youth (PDF): Journal article providing guidance to clinicians on the clinical management of extrapyramidal side effects of second-generation antipsychotics.
- Treatment Recommendations for Metabolic Complications Associated with SGA Use in Children: A quick reference guide (PDF)